TYCC
LOGC

Texas Yale Capital Corp’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Texas Yale Capital Corp’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$5K Hold
2022
Q2 		$7K Hold
2022
Q1 		$14K Hold
2021
Q4 		$46K Hold
2021
Q3 		$92K Hold
2021
Q2 		$89K Buy
2021
Q1 		$73K Buy